Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors

J Am Acad Dermatol. 2018 Mar;78(3):592-595. doi: 10.1016/j.jaad.2017.09.051. Epub 2017 Oct 4.

Authors

Luca Fania¹, Adele Salemme², Alessia Provini², Gianluca Pagnanelli², Maria Chiara Collina², Damiano Abeni², Biagio Didona², Giovanni Di Zenzo², Cinzia Mazzanti²

Affiliations

¹ Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy. Electronic address: [email protected].
² Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy.

PMID: 28987492
DOI: 10.1016/j.jaad.2017.09.051

No abstract available

Publication types

Letter

MeSH terms

Adamantane / adverse effects
Adamantane / analogs & derivatives
Aged
Aged, 80 and over
Autoantibodies / blood*
Autoantigens / immunology*
Collagen Type XVII
Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
Epitopes
Female
Humans
Immunoglobulin A / blood
Immunoglobulin E / blood
Immunoglobulin G / blood
Linagliptin / adverse effects
Male
Membrane Glycoproteins / immunology*
Middle Aged
Nitriles / adverse effects
Non-Fibrillar Collagens / immunology*
Pemphigoid, Bullous / blood*
Pemphigoid, Bullous / chemically induced
Piperidines / adverse effects
Pyrrolidines / adverse effects
Sitagliptin Phosphate / adverse effects
Uracil / adverse effects
Uracil / analogs & derivatives
Vildagliptin

Substances

Autoantibodies
Autoantigens
BP230 protein, mouse
Dipeptidyl-Peptidase IV Inhibitors
Epitopes
Immunoglobulin A
Immunoglobulin G
Membrane Glycoproteins
Nitriles
Non-Fibrillar Collagens
Piperidines
Pyrrolidines
Immunoglobulin E
Linagliptin
Uracil
Vildagliptin
alogliptin
Adamantane
Sitagliptin Phosphate